|
Immunotherapy
Citations 331-340 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Novel antimalarial antibodies highlight the importance of the antibody Fc region in mediating protection
- Richard J. Pleass, Solabomi A. Ogun, David H. McGuinness, Jan G. J. van de Winkel, Anthony A. Holder, and Jenny M. Woof
Blood 2003; 102: 4424-4430.
[Abstract]
[Full text]
[PDF]
Fas ligation induces IL-1 -dependent maturation and IL-1-independent survival of dendritic cells: different roles of ERK and NF- B signaling pathways
- Zhenhong Guo, Minghui Zhang, Huazhang An, Weilin Chen, Shuxun Liu, Jun Guo, Yizhi Yu, and Xuetao Cao
Blood 2003; 102: 4441-4447.
[Abstract]
[Full text]
[PDF]
Two-signal requirement for activation and effector function of natural killer cell response to allogeneic tumor cells
- Jian-Xin Gao, Xingluo Liu, Jing Wen, Michael A. Caligiuri, Iwona Stroynowski, Pan Zheng, and Yang Liu
Blood 2003; 102: 4456-4463.
[Abstract]
[Full text]
[PDF]
NK-cell purging of leukemia: superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade
- Crystal Y. Koh, John R. Ortaldo, Bruce R. Blazar, Michael Bennett, and William J. Murphy
Blood 2003; 102: 4067-4075.
[Abstract]
[Full text]
[PDF]
Interleukin-21 inhibits dendritic cell activation and maturation
- Katja Brandt, Silvia Bulfone-Paus, Donald C. Foster, and René Rückert
Blood 2003; 102: 4090-4098.
[Abstract]
[Full text]
[PDF]
Inhibition of invariant chain expression in dendritic cells presenting endogenous antigens stimulates CD4+ T-cell responses and tumor immunity
- Yangbing Zhao, David Boczkowski, Smita K. Nair, and Eli Gilboa
Blood 2003; 102: 4137-4142.
[Abstract]
[Full text]
[PDF]
Transplantation for multiple myeloma: who, when, how often?
- Joan Bladé, David H. Vesole, and Morie Gertz
Blood 2003; 102: 3469-3477.
[Full text]
[PDF]
IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1
- Jana Barlic, Joan M. Sechler, and Philip M. Murphy
Blood 2003; 102: 3494-3503.
[Abstract]
[Full text]
[PDF]
Transient down-modulation of CD20 by rituximab in patients with chronic lymphocytic leukemia
- Iman Jilani, Susan O'Brien, Taghi Manshuri, Deborah A. Thomas, Vilmos A. Thomazy, Maha Imam, Sana Naeem, Srdan Verstovsek, Hagop Kantarjian, Francis Giles, Michael Keating, and Maher Albitar
Blood 2003; 102: 3514-3520.
[Abstract]
[Full text]
[PDF]
Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region
- Mirjam H. M. Heemskerk, Manja Hoogeboom, Roelof A. de Paus, Michel G. D. Kester, Menno A. W. G. van der Hoorn, Els Goulmy, Roel Willemze, and J. H. Frederik Falkenburg
Blood 2003; 102: 3530-3540.
[Abstract]
[Full text]
[PDF]
|
|
